Valeant Pharmaceuticals' business model: the repercussions for patients and the health care system, Senate hearing 114-846, Serial no. 114-24, April 27, 2016.
Saved in:
| Corporate Author: | |
|---|---|
| Format: | Government Document Book |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
[2022?]
|
| Item Description: | Shipping List #: 2022-0268-P. Shipping List Date: 09/12/2022. |
|---|